- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UK-12-0022566

Saurya Pharmaceutical Private Limited
About Saurya Pharmaceutical Private Limited
Data last updated:
Saurya Pharmaceutical Private Limited is a private limited company based in Rudrapur, Uttarakhand, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 November 2022.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2022PTC014910. Its GSTIN is 05ABJCS7981F1ZX (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Rekha Tiwari and Sumit Kumar Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khet No 232/2 Officer Colony Bhurarani, Rudrapur, Uttarakhand, India – 263153.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.02 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2,404 (net margin 0.1%) and EBITDA of ₹2.73 Lakh (EBITDA margin 14.3%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Saurya Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-12-0022566).
Company details
Recognitions & Rankings of Saurya Pharmaceutical
Contact details
Saurya Pharmaceutical Private Limited's registered office is in Rudrapur, Uttarakhand.
- Registered AddressKhet No 232/2 Officer Colony Bhurarani, Rudrapur, Uttarakhand, India – 263153
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saurya Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Saurya Pharmaceutical Private Limited, buy the company report.
Financials of Saurya Pharmaceutical Private Limited
FY 2025 filings availableSaurya Pharmaceutical Private Limited reported revenue of ₹19.02 Lakh (up 267% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 267% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.73 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2,404 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 14.3% | ||
| Net Profit Margin | 0.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Saurya Pharmaceutical Private Limited, buy the company report.
Board of directors of Saurya Pharmaceutical Private Limited
Saurya Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Tiwari | Additional Director | 16 May 2025 | 1 Years 5 Months | Current |
| Rekha Tiwari | Director | 23 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Saurya Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Satwisha Healthcare (OPC) Private Limited | ₹19.09 Lakh (FY 2025) | 2.0% | Guwahati, Assam, India | |||
| Manish Bearings Private Limited | ₹19.09 Lakh (FY 2025) | -52.0% | Delhi, India | |||
| Atex Engineering Systems Private Limited | ₹19.08 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Bienistar Pharma Private Limited | ₹19.03 Lakh (FY 2025) | 38.0% | Mumbai, Maharashtra, India | |||
| LJP Consumer Products Private Limited | ₹19.02 Lakh (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Saurya Pharmaceutical Private Limitedthis company | ₹19.02 Lakh (FY 2025) | ₹2,404 | 0.1% | 267.0% | Rudrapur, Uttarakhand, India | |
| Amea Cold Private Limited | ₹19.01 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Alagu Export and Import Private Limited | ₹19 Lakh (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Lifesaving Healthcare (OPC) Private Limited | ₹18.99 Lakh (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Suryawanshi Global Private Limited | ₹18.98 Lakh (FY 2025) | 2.0% | Bhiwandi, Maharashtra, India | |||
| Vanita Devi Agro Producer Company Limited | ₹18.97 Lakh (FY 2024) | 110.0% | Nanded, Maharashtra, India |
To see the full peer comparison of Saurya Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Feb 2023 | 100681083 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Saurya Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saurya Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saurya Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05ABJCS7981F1ZX | Uttarakhand | Active | 16 Aug 2023 |
To see the full GST registrations and return filing status of Saurya Pharmaceutical Private Limited, buy the company report.
Recent activity
Saurya Pharmaceutical Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Saurabh Tiwari ceased to be Managing Director on 16 Jun 2025.
Frequently asked questions
Saurya Pharmaceutical is an active private limited company based in Rudrapur, Uttarakhand, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 November 2022 (4+ years old) and is registered under CIN U24304UR2022PTC014910.
Saurya Pharmaceutical has 2 current directors:
- Sumit Kumar Tiwari - Additional Director
- Rekha Tiwari - Director
The latest financial statements of Saurya Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Saurya Pharmaceutical is 05ABJCS7981F1ZX, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Saurya Pharmaceutical is U24304UR2022PTC014910. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saurya Pharmaceutical was incorporated on 23 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Saurya Pharmaceutical by revenue are Satwisha Healthcare (OPC) Private Limited, Manish Bearings Private Limited, Atex Engineering Systems Private Limited, Bienistar Pharma Private Limited, LJP Consumer Products Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Saurabh Tiwari ceased to be Managing Director on 16 Jun 2025. Sumit Kumar Tiwari was appointed as Additional Director on 16 May 2025. Sumit Kumar Tiwari ceased to be Additional Director on 11 Dec 2023. Saurya Pharmaceutical has 4 board changes on record in total.
Yes, Saurya Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-12-0022566).
The registered office of Saurya Pharmaceutical is at Khet No 2322 Officer Colony Bhurarani, Rudrapur, Uttarakhand, India – 263153.
Saurya Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

